Related Experiment Video

Updated: Jun 21, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Molecular targets for antiviral therapy of cytomegalovirus infections

Manfred Marschall1, Thomas Stamminger

  • 1Institute for Clinical & Molecular Virology, University of Erlangen-Nuremberg, Schlossgarten 4, 91054 Erlangen, Germany. manfred.marschall@viro.med.uni-erlangen.de

Future Microbiology
|August 8, 2009
PubMed

Insights

New antiviral strategies are needed for human cytomegalovirus (CMV) infections, which cause severe illness in immunocompromised patients and congenital infections. This review explores novel viral and host targets to develop effective treatments against drug-resistant CMV.

Area of Science:

  • Virology
  • Immunology
  • Drug Discovery

Background:

  • Human cytomegalovirus (CMV) infections pose significant health risks, causing severe morbidity and mortality in immunocompromised individuals.
  • Current antiviral therapies are insufficient, and treatment options for congenital CMV infections are limited, highlighting an urgent need for new drugs.

Purpose of the Study:

  • This review identifies and analyzes key target molecules for developing innovative anti-CMV therapies.
  • It focuses on viral proteins and host factors crucial for viral replication to overcome existing treatment limitations.

Main Methods:

  • The review synthesizes current research on potential anti-CMV drug targets.
  • It examines viral immediate-early proteins, DNA replication proteins, and regulatory protein kinases.
  • Special attention is given to host factors like platelet-derived growth factor (PDGF) receptor tyrosine kinase and cyclin-dependent kinases.

Main Results:

  • Several viral proteins and host factors have been identified as promising targets for novel anti-CMV drugs.
  • Targeting host factors, in addition to viral components, may offer a strategy to combat drug-resistant CMV variants.

Conclusions:

  • The development of potent, safe, and well-tolerated antiviral drugs against CMV is critically needed.
  • Combined targeting of viral and cellular factors presents a promising approach to overcome CMV resistance and improve treatment outcomes.

More Related Videos

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates05:53

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates

Published on: July 6, 2013

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A1606:03

Use of Viral Entry Assays and Molecular Docking Analysis for the Identification of Antiviral Candidates against Coxsackievirus A16

Published on: July 15, 2019

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...